The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Early Lessons from the COVID-19 Pandemic: A Q&A with Chris Phillips, MD

Early Lessons from the COVID-19 Pandemic: A Q&A with Chris Phillips, MD

December 7, 2020 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

TR: What have been your patients’ concerns about the effects of immunosuppressant medications during this pandemic?
Dr. Phillips: My patients have been all over the spectrum. Early in the pandemic, we messaged patients they shouldn’t stop treatment, and we wanted to talk to them about their concerns. As COVID-19 has progressed, we’ve gotten data from the COVID-19 Global Rheumatology Alliance about rheumatic patients who have contracted COVID-19. The data have been reassuring suggesting prednisone above 10 mg is a risk factor for complications, but the other drugs we use seem to not have increased complication risks. Speaking for myself, that data have given me a reasonable comfort level.

You Might Also Like
  • The Pandemic in Rural America: A Q&A with Chris Morris, MD
  • The COVID-19 Pandemic & the ACR’s Response
  • Dr. Chris Phillips Competes in Triathlons
Also By This Author
  • Vaccines and Biologics: What Rheumatologists Need to Know

TR: What are you telling your patients about a possible COVID-19 vaccine, and are you using the ACR vaccine guideline/COVID-19-related guidance?
Dr. Phillips: We are in the process of rolling out that literature in our office. My messaging is following closely what is in the document. I’m focusing on vaccines being generally safe.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The conversation I have been having with my patients is that they—and myself—should be prepared to get the vaccine at some point. For the vast majority of people, the risk to benefit [profile] is going to [favor] taking the vaccine. It’s hard to give firm guidance when we don’t know which vaccine(s) will be available.

TR: What is next for your practice?
Dr. Phillips: The biggest point for me is I don’t think we can begin talking about recovery from COVID-19 right now. The first battle is over, but the next one is yet to come. I’m anxious about how winter is going to go. I am hopeful that those of us who got through the initial storm—physically and financially—are equally successful in weathering the second storm.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We have learned to be much more flexible. Over the next few months, we can’t assume anything about what the environment will look like. We have to be super flexible. We can’t assume things are fine and will continue to go that way, so that our bank accounts will stay full, and we will stay healthy. We can no longer take any of these things for granted.


Kurt Ullman is a freelance writer based in Indiana.

Pages: 1 2 | Single Page

Filed Under: Professional Topics Tagged With: COVID-19, telemedicine

You Might Also Like:
  • The Pandemic in Rural America: A Q&A with Chris Morris, MD
  • The COVID-19 Pandemic & the ACR’s Response
  • Dr. Chris Phillips Competes in Triathlons
  • Adapting Care During COVID-19: Q&A with Brett Smith, DO

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)